Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Use financial data to refine your budget with practical steps that help identify waste and improve allocation. This intro explains a data-driven approach to smarter budgeting.
27,071 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Space-focused investors have watched Redwire stock keep dropping as headlines swirl about contracts, funding, and exe...
Bitcoin failed to clear a key ceiling near $63,000 as a high-flying altcoin, BEAT, gapped higher by about 40%. Trader...
Wendy's has surged about 40% over the past week, attracting intense options activity and renewed bets on a turnaround...
Volatility tests reshape the defensive playbook in consumer staples. Coca-Cola edges ahead of PepsiCo on cash flow an...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
A reported plan for Apple to source memory chips from a Chinese supplier could upend Micron’s mobile business and cha...
Korean equities ended a choppy week higher after reports that Anthropic and Samsung were in talks. The move capped a ...
TeraWulf stock this year has surged as the company pivots from crypto mining to long-term compute infrastructure afte...
As Berkshire's new leader, Greg Abel faces a massive cash pile. This article examines why Alphabet is the target, wha...
Goldman Sachs warns that China's oil demand may not return to its pre-crisis trajectory, highlighting a potential, la...
Jim Cramer argues that the MAG 7 must be analyzed separately, not as a single basket, outlining five core reasons eac...